Cargando…
Presence of Circulating Anti-Myosin Antibodies in Endomyocardial Fibrosis
BACKGROUND: Endomyocardial Fibrosis (EMF) is a tropical restrictive cardiomyopathy of unknown etiology with high prevalence in Sub-Saharan Africa, for which it is unclear whether the primary target of injury is the endocardial endothelium, the subendocardial fibroblast, the coronary microcirculation...
Autores principales: | Mocumbi, Ana Olga, Latif, Najma, Yacoub, Magdi H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857887/ https://www.ncbi.nlm.nih.gov/pubmed/20422043 http://dx.doi.org/10.1371/journal.pntd.0000661 |
Ejemplares similares
-
Genetic susceptibility to endomyocardial fibrosis
por: Beaton, Andrea, et al.
Publicado: (2014) -
Endomyocardial fibrosis: A form of endemic restrictive cardiomyopathy
por: Mocumbi, Ana Olga
Publicado: (2012) -
Active schistosomiasis, severe hypereosinophilia and rapid progression of chronic endomyocardial fibrosis
por: Mocumbi, AO, et al.
Publicado: (2016) -
Endomyocardial fibrosis
por: Gutierrez, Paulo Sampaio, et al.
Publicado: (2017) -
Electrocardiogram in Endomyocardial Fibrosis
por: Tharakan, Jaganmohan A
Publicado: (2011)